Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Change in Accured Expenses (2010 - 2026)

Amarin Corp Plc\Uk (AMRN) posted quarterly Change in Accured Expenses of -$15.4 million for Q2 2026, down 165.63% year-over-year from $23.5 million in Q2 2025, and down 4.28% quarter-over-quarter from -$14.8 million in Q1 2026.

Amarin Corp Plcuk (AMRN) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Change in Accured Expenses for 17 consecutive years, with -$15.4 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Change in Accured Expenses fell 165.63% year-over-year to -$15.4 million; the TTM figure through Jun 2026 stood at -$21.8 million (up 51.23% YoY), while the FY2025 annual figure was $14.5 million, up 118.85% from the prior year.
  • Change in Accured Expenses declined to -$15.4 million in Q2 2026 per AMRN's latest filing, from -$14.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $61.0 million in Q2 2022 and bottomed at -$69.7 million in Q1 2022.
  • Historically, Change in Accured Expenses has averaged -$10.9 million across 5 years, with a median of -$15.0 million in 2023.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 1175.14% — and 2025, when it surged 176.85%.
  • Amarin Corp Plc\Uk's Change in Accured Expenses stood at -$28.1 million in 2022, then jumped by 73.09% to -$7.6 million in 2023, then slumped by 186.16% to -$21.6 million in 2024, then jumped by 156.59% to $12.2 million in 2025, then tumbled by 226.36% to -$15.4 million in 2026.
  • Business Quant data shows AMRN's Change in Accured Expenses at -$15.4 million in Q2 2026, -$14.8 million in Q1 2026, and $12.2 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 2.32 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 1.20 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 852.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 338.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn -15.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.45 Mn
Jun 30, 2026 -15.45 Mn
Mar 31, 2026 -14.82 Mn
Mar 31, 2026 -14.82 Mn
Dec 31, 2025 12.23 Mn
Dec 31, 2025 12.23 Mn
Sep 30, 2025 -3.71 Mn
Sep 30, 2025 -3.71 Mn
Jun 30, 2025 23.54 Mn
Jun 30, 2025 23.54 Mn
Mar 31, 2025 -17.54 Mn
Mar 31, 2025 -17.54 Mn
Dec 31, 2024 -21.61 Mn
Dec 31, 2024 -21.61 Mn
Sep 30, 2024 -28.99 Mn
Sep 30, 2024 -28.99 Mn
Jun 30, 2024 8.50 Mn
Jun 30, 2024 8.50 Mn
Mar 31, 2024 -34.90 Mn
Mar 31, 2024 -34.90 Mn